PDF下载 ( 1588 KB)
Expert consensus on transjugular intrahepatic portosystemic shunt
-
摘要:
<正>经颈静脉肝内门体分流术（TIPS）是指经颈静脉入路从肝静脉穿刺肝内门静脉,在肝静脉与门静脉之间建立门-体分流道,以达到降低门静脉压力、治疗食管胃静脉曲张破裂出血和顽固性腹腔积液等一系列门静脉高压并发症的微创介入治疗技术。自20世纪80年代末R9ssle等[1]首次采用TIPS成功治疗1例门静脉高压静脉曲张出血伴大量腹腔积液患者以来,该技术广泛用于治疗门静脉高压并发症,适应证也逐步扩展[2-3]。TIPS技术20世纪90年代初被引入中
-
关键词:
- 门体分流术,经颈静脉肝内 /
- 共识
-
Key words:
- portasystemic shunt, transjugular intrahepatic /
- consensus
-
[1]ROSSLE M, RICHTER GM, NOLDGE G, et al.New non-operative treatment for variceal haemorrhage[J].Lancet, 1989, 2 (8655) :153. [2]ROSSLE M.TIPS:25 years later[J].J Hepatol, 2013, 59 (5) :1081-1093. [3]Group of Gastrointestinal Intervention, Chinese Society of Gastroenterology, Chinese Medical Association.Consensus on transjugular intrahepatic portosystemic shunt for treatment of cirrhotic portal hypertension[J].J Clin Hepatol, 2014, 30 (3) :210-213. (in Chinese) 中华医学会消化病学分会消化介入学组.经颈静脉肝内门体静脉分流术治疗肝硬化门静脉高压共识意见[J].临床肝胆病杂志, 2014, 30 (3) :210-213. [4] XU K, ZHANG HG, HE FX, et al.Preliminary report on portal hypertention in liver cirrhosis treated by transjugular intrahepatic portosystemic stent shunt (analysis of 8 cases) [J].Chin J Radiol, 1993, 27 (5) :294-297. (in Chinese) 徐克, 张汉国, 何芳显, 等.经颈静脉肝内门腔静脉内支架分流术治疗肝硬变门脉高压症 (附八例分析) [J].中华放射学杂志, 1993, 27 (5) :294-297. [5]Intervention Group of the Editorial Board of Chinese Journal of Radiology.Clinical guidelines for transjugular intrahepatic portosystemic shunt[J].Chin J Radiol, 2004, 38 (12) :1329-1332. (in Chinese) 《中华放射学杂志》编委会介入组.经颈静脉肝内门体静脉分流术临床技术指南[J].中华放射学杂志, 2004, 38 (12) :1329-1332. [6]CHENG L, WANG CS, BAI XM, et al.Analysis of the relevant factors of coagulation dysfunction after transjugular intrahepatic portosystemic shunt operation in patients with decompensated liver cirrhosis[J].Chin J Radiol, 2016, 50 (11) :865-869. (in Chinese) 程龙, 王才善, 白旭明, 等.肝硬化失代偿期经颈静脉肝内门体分流术后凝血功能障碍的相关因素分析[J].中华放射学杂志, 2016, 50 (11) :865-869. [7]CHENG L, BAI XM, GU XS, et al.Influence of transjugular intrahepatic portosystemic shunt on fibrinogen content in patients with esophagogastric variceal bleeding[J].Chin J Radiol, 2015, 49 (11) :868-869. (in Chinese) 程龙, 白旭明, 顾星石, 等.经颈静脉门体分流术对食管胃底静脉曲张破裂出血患者纤维蛋白原含量的影响[J].中华放射学杂志, 2015, 49 (11) :868-869. [8] LUO ZL, ZHAO JB, FENG C, et al.Interventional revision method on shunt dysfunction after transjugular intrahepatic portosystemic shunt using covered stents[J].Chin J Radiol, 2015, 49 (10) :754-757. (in Chinese) 罗泽龙, 赵剑波, 冯超, 等.全覆膜支架经颈静脉肝内门腔静脉分流术后分流道功能不全的介入处理方法[J].中华放射学杂志, 2015, 49 (10) :754-757. [9]YE P, CHEN Y, ZHAO JB, et al.Clinical effect of balloon-assisted transjugular intrahepatic portosystemic shunt in treatment of symptomatic chronic portal thrombosis with complete occlusion[J].Chin J Radiol, 2014, 48 (11) :958-960. (in Chinese) 叶鹏, 陈勇, 赵剑波, 等.球囊辅助经颈静脉肝内门体静脉分流术治疗症状性完全闭塞型慢性门静脉血栓[J].中华放射学杂志, 2014, 48 (11) :958-960. [10] ZHAO JB, CHEN Y, HE XF, et al.Transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene covered stent[J].Chin J Radiol, 2013, 47 (7) :588-592. (in Chinese) 赵剑波, 陈勇, 何晓峰, 等.采用聚四氟乙烯覆膜支架行经颈静脉肝内门腔分流术的临床疗效观察[J].中华放射学杂志, 2013, 47 (7) :588-592. [11]ZHAO HW, LIU FQ, YUE ZD, et al.Clinical effects of transjugular interventional stent-shunt therapy in hepatic myelopathy after transjugular intrahepatic portosystemic shunt[J].Chin J Radiol, 2013, 47 (3) :239-244. (in Chinese) 赵洪伟, 刘福全, 岳振东, 等.经颈静脉途径介入干预经颈静脉肝内门体静脉分流术分流后肝性脊髓病的临床疗效[J].中华放射学杂志, 2013, 47 (3) :239-244. [12]LIU FQ, YUE ZD, ZHAO HW, et al.Clinical analysis of long-term outcomes of re-intervention of transjugular intrahepatic porto-systemic shunt[J].Chin J Radiol, 2012, 46 (9) :830-835. (in Chinese) 刘福全, 岳振东, 赵洪伟, 等.经颈静脉肝内门-体分流术后再次介入治疗肝硬化门静脉高压长期疗效及再次手术原因分析[J].中华放射学杂志, 2012, 46 (9) :830-835. [13] ZHANG LP, CHEN ST, SHI XL, et al.Adopting wedge hepatic venography with CO2 during transjugular intrahepatic portosystemic shunt procedures[J].Chin J Radiol, 2012, 46 (5) :456-458. (in Chinese) 张林鹏, 陈松涛, 石秀兰, 等.经颈静脉楔入法肝静脉CO2造影术在经颈静脉肝内门体分流术中的应用[J].中华放射学杂志, 2012, 46 (5) :456-458. [14]SHAO S, JIANG ZB, WANG J, et al.Multidetector row CT study of percutaneous transhepatic intrahepatic portosystemic shunt[J].Chin J Radiol, 2011, 45 (9) :854-857. (in Chinese) 邵硕, 姜在波, 王劲, 等.经皮经肝肝内门体分流术的多层CT影像研究[J].中华放射学杂志, 2011, 45 (9) :854-857. [15]JIANG ZB, LI MA, SHAN H, et al.Creative intrahepatic portosystemic shunt by percutaneous transhepatic approach[J].Chin J Radiol, 2011, 45 (1) :89-91. (in Chinese) 姜在波, 李名安, 单鸿, 等.经皮经肝穿刺改良式肝内门体分流术的临床应用[J].中华放射学杂志, 2011, 45 (1) :89-91. [16]JIANG YB, ZHANG XT, ZHANG W, et al.A comparison of clinical efficacy between covered stent-grafts and bare stents in transjuglar in-trahepatic portosystemic shunt[J].Chin J Radiol, 2010, 44 (3) :308-311. (in Chinese) 姜永滨, 张曦彤, 张伟, 等.经颈静脉肝内门体分流术中覆膜支架与非覆膜支架效果的比较[J].中华放射学杂志, 2010, 44 (3) :308-311. [17]SHI GJ, TENG GJ, CAO AH, et al.A comparison of clinical efficacy between covered stent-grafts and bare stents in transjuglar in-trahepatic portosystemic shunt[J].Chin J Radiol, 2009, 43 (11) :1201-1206. (in Chinese) 石红建, 滕皋军, 曹爱红, 等.内皮祖细胞种植支架在经颈静脉肝内门体分流术中应用的实验研究[J].中华放射学杂志, 2009, 43 (11) :1201-1206. [18]LU Q, AN YL, DENG G, et al.Experimental comparison study of the tissue characteristics in transjugular intrahepalic portosystemic shunt and vascular stent[J].Chin J Radiol, 2009, 43 (1) :82-87. (in Chinese) 卢勤, 安艳丽, 邓钢, 等.肝内门腔分流术支架与血管支架组织成分的对比研究[J].中华放射学杂志, 2009, 43 (1) :82-87. [19]HUANG YH, CHEN W, LI JP, et al.Hemodynamic changes in liver measured by multi-imaging methods before and after transjugular intrahepatic portosystemic stent-shunt[J].Chin J Radiol, 2007, 41 (12) :1374-1378. (in Chinese) 黄勇慧, 陈伟, 李家平, 等.经颈静脉肝内门腔分流术后肝血流变化的综合影像评价[J].中华放射学杂志, 2007, 41 (12) :1374-1378. [20]SHEN Q, JIANG ZP, REN LJ, et al.The clinical choice in the method of interventional treatment to portal hypertension[J].Chin J Radiol, 2004, 38 (10) :1019-1024. (in Chinese) 申麒, 蒋忠仆, 任丽军, 等.门静脉高压症介入治疗术式的临床选择[J].中华放射学杂志, 2004, 38 (10) :1019-1024. [21]ZHANG XT, XU K, JIANG H, et al.Experimental study on the creation of modified TIPSS[J].Chin J Radiol, 2003, 37 (2) :156-160. (in Chinese) 张曦彤, 徐克, 姜宏, 等.经颈静脉肝内门体静脉内支架分流术术式改良的实验研究[J].中华放射学杂志, 2003, 37 (2) :156-160. [22]JIANG ZB, SHAN H, GUAN SH, et al.Palliative treatment of TIPS to portal vein tumor thrombosis complicated with portal vein hypertension[J].Chin J Radiol, 2002, 36 (12) :1075-1079. (in Chinese) 姜在波, 单鸿, 关守海, 等.门静脉癌栓合并门脉高压症的TIPS姑息治疗[J].中华放射学杂志, 2002, 36 (12) :1075-1079. [23]SHAN H, GUAN SH, JIANG ZB, et al.Extensive techniques of TIPS in Buddi-Chiari syndrome with occlusive hepatic veins[J].Chin J Radiol, 2002, 36 (9) :787-791. (in Chinese) 单鸿, 关守海, 姜在波, 等.改良式经颈静脉肝内门腔静脉分流术治疗肝静脉闭塞型Buddi-Chiari综合征[J].中华放射学杂志, 2002, 36 (9) :787-791. [24]ZHANG XT, XU K, DAI X, et al.TIPS treatment for complicated Budd-Chiari syndrome[J].Chin J Radiol, 2001, 35 (1) :34-36. (in Chinese) 张曦彤, 徐克, 戴旭, 等.经颈静脉肝内门腔分流术治疗复杂型Budd-Chiari综合征[J].中华放射学杂志, 2001, 35 (1) :34-36. [25]BOYER TD, HASKAL ZJ.The Role of Transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension:update 2009[J].Hepatology, 2010, 51 (1) :306. [26]de FRANCHIS R.Expanding consensus in portal hypertension:report of the Baveno VI Consensus Workshop:stratifying risk and individualizing care for portal hypertension[J].J Hepatol, 2015, 63 (3) :743-752. [27]GARCIA-TSAO G, ABRALDES JG, BERZIGOTTI A, et al.Portal hypertensive bleeding in cirrhosis:risk stratification, diagnosis, and management:2016 practice guidance by the American Association for the study of liver diseases[J].Hepatology, 2017, 65 (1) :310-335. [28]FAGIUOLI S, BRUNO R, DEBERNARDI VENON W, et al.Consensus conference on TIPS management:techniques, indications, contraindications[J].Dig Liver Dis, 2017, 49 (2) :121-137. [29]GUYATT GH, OXMAN AD, VIST GE, et al.GRADE:an emerging consensus on rating quality of evidence and strength of recommendations[J].BMJ, 2008, 336 (7650) :924-926. [30]GARCIA-TSAO G, BOSCH J.Management of varices and variceal hemorrhage in cirrhosis[J].N Engl J Med, 2010, 362 (9) :823-832. [31]VANGELI M, PATCH D, BURROUGHS AK.Salvage tips for uncontrolled variceal bleeding[J].J Hepatol, 2002, 37 (5) :703-704. [32]MONESCILLO A, MARTíNEZ-LAGARES F, RUIZ-DEL-ARBOL L, et al.Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding[J].Hepatology, 2004, 40 (4) :793-801. [33]GARCIA-PAGAN JC, CACA K, BUREAU C, et al.Early use of TIPS in patients with cirrhosis and variceal bleeding[J].N Engl J Med, 2010, 362 (25) :2370-2379. [34]GARCIA-PAGáN JC, di PASCOLI M, CACA K, et al.Use of early-TIPS for high-risk variceal bleeding:results of a postRCT surveillance study[J].J Hepatol, 2013, 58 (1) :45-50. [35]HERNANDEZ-GEA V, PROCOPET B, GIRáLDEZá, et al.Early-TIPS improves survival in high-risk variceal bleeders.Results of a multicenter variceal bleeding observational study[J].Hepatology, 2016, 63 (1) :47a-48a. [36]RUDLER M, CLUZEL P, CORVEC TL, et al.Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival[J].Aliment Pharmacol Ther, 2014, 40 (9) :1074-1080. [37]BOSCH J, GARCIA-PAGAN JC.Prevention of variceal rebleeding[J].Lancet, 2003, 361 (9361) :952-954. [38]ZHENG M, CHEN Y, BAI J, et al.Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients:meta-analysis update[J].J Clin Gastroenterol, 2008, 42 (5) :507-516. [39]HOLSTER IL, TJWA ET, MOELKER A, et al.Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy+β-blocker for prevention of variceal rebleeding[J].Hepatology, 2016, 63 (2) :581-589. [40]SARIN SK, LAHOTI D, SAXENA SP, et al.Prevalence, classification and natural history of gastric varices:a long-term followup study in 568 portal hypertension patients[J].Hepatology, 1992, 16 (6) :1343-1349. [41]KIM T, SHIJO H, KOKAWA H, et al.Risk factors for hemorrhage from gastric fundal varices[J].Hepatology, 1997, 25 (2) :307-312. [42]CHAU TN, PATCH D, CHAN YW, et al.“Salvage”transjugular intrahepatic portosystemic shunts:gastric fundal compared with esophageal variceal bleeding[J].Gastroenterology, 1998, 114 (5) :981-987. [43]TRIPATHI D, THERAPONDOS G, JACKSON E, et al.The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices:clinical and haemodynamic correlations[J].Gut, 2002, 51 (2) :270-274. [44]LO GH, LIANG HL, CHEN WC, et al.A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding[J].Endoscopy, 2007, 39 (8) :679-685. [45]MAHADEVA S, BELLAMY MC, KESSEL D, et al.Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding[J].Am J Gastroenterol, 2003, 98 (12) :2688-2693. [46]CHOI SY, WON JY, KIM KA, et al.Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO) [J].Eur Radiol, 2011, 21 (1) :122-129. [47]SAAD WE, DARCY MD.Transjugular intrahepatic portosystemic shunt (TIPS) versus balloon-occluded retrograde transvenous obliteration (BRTO) for the management of gastric varices[J].Semin Intervent Radiol, 2011, 28 (3) :339-349. [48]PATEL A, FISCHMAN AM, SAAD WE.Balloon-occluded retrograde transvenous obliteration of gastric varices[J].AJR Am J Roentgenol, 2012, 199 (4) :721-729. [49]SABRI SS, ABI-JAOUDEH N, SWEE W, et al.Short-term rebleeding rates for isolated gastric varices managed by transjugular intrahepatic portosystemic shunt versus balloon-occluded retrograde transvenous obliteration[J].J Vasc Interv Radiol, 2014, 25 (3) :355-361. [50]ROSSLE M, GERBES AL.TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax:a critical update[J].Gut, 2010, 59 (7) :988-1000. [51]LEBREC D, GIUILY N, HADENGUE A, et al.Transjugular intrahepatic portosystemic shunts:comparison with paracentesis in patients with cirrhosis and refractory ascites:a randomized trial.French Group of Clinicians and a Group of Biologists[J].J Hepatol, 1996, 25 (2) :135-144. [52]ROSSLE M, OCHS A, GüLBERG V, et al.A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites[J].N Engl J Med, 2000, 342 (23) :1701-1707. [53]GINES P, URIZ J, CALAHORRA B, et al.Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis[J].Gastroenterology, 2002, 123 (6) :1839-1847. [54]SANYAL AJ, GENNING C, REDDY KR, et al.The North American Study for the Treatment of Refractory Ascites[J].Gastroenterology, 2003, 124 (3) :634-641. [55]SALERNO F, MERLI M, RIGGIO O, et al.Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites[J].Hepatology, 2004, 40 (3) :629-635. [56]NARAHARA Y, KANAZAWA H, FUKUDA T, et al.Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function:a prospective randomized trial[J].J Gastroenterol, 2011, 46 (1) :78-85. [57]D'AMICO G, LUCA A, MORABITO A, et al.Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites:a meta-analysis[J].Gastroenterology, 2005, 129 (4) :1282-1293. [58]DELTENRE P, MATHURIN P, DHARANCY S, et al.Transjugular intrahepatic portosystemic shunt in refractory ascites:a meta-analysis[J].Liver Int, 2005, 25 (2) :349-356. [59]SAAB S, NIETO JM, LEWIS SK, et al.TIPS versus paracentesis for cirrhotic patients with refractory ascites[J].Cochrane Database Syst Rev, 2006, (4) :CD004889. [60]ALBILLOS A, BANARES R, GONZALEZ M, et al.A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites[J].J Hepatol, 2005, 43 (6) :990-996. [61]SALERNO F, CAMMA C, ENEA M, et al.Transjugular intrahepatic portosystemic shunt for refractory ascites:a meta-analysis of individual patient data[J].Gastroenterology, 2007, 133 (3) :825-834. [62]BAI M, QI XS, YANG ZP, et al.TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites:an updated meta-analysis[J].World J Gastroenterol, 2014, 20 (10) :2704-2714. [63]BUREAU C, THABUT D, OBERTI F, et al.Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites[J].Gastroenterology, 2017, 152 (1) :157-163. [64]RABIE RN, CAZZANIGA M, SALERNO F, et al.The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt[J].Am J Gastroenterol, 2009, 104 (10) :2458-2466. [65]BUREAU C, METIVIER S, D'AMICO M, et al.Serum bilirubin and platelet count:a simple predictive model for survival in patients with refractory ascites treated by TIPS[J].J Hepatol, 2011, 54 (5) :901-907. [66]STRAUSS RM, MARTIN LG, KAUFMAN SL, et al.Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax[J].Am J Gastroenterol, 1994, 89 (9) :1520-1522. [67]GORDON FD, ANASTOPOULOS HT, CRENSHAW W, et al.The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt[J].Hepatology, 1997, 25 (6) :1366-1369. [68]SIEGERSTETTER V, DEIBERT P, OCHS A, et al.Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt:long-term results in 40 patients[J].Eur J Gastroenterol Hepatol, 2001, 13 (5) :529-534. [69]JEFFRIES MA, KAZANJIAN S, WILSON M, et al.Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax[J].Liver Transpl Surg, 1998, 4 (5) :416-423. [70]SPENCER EB, COHEN DT, DARCY MD.Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax[J].J Vasc Interv Radiol, 2002, 13 (4) :385-390. [71]WILPUTTE JY, GOFFETTE P, ZECH F, et al.The outcome after transjugular intrahepatic portosystemic shunt (TIPS) for hepatic hydrothorax is closely related to liver dysfunction:a long-term study in 28 patients[J].Acta Gastroenterol Belg, 2007, 70 (1) :6-10. [72]DHANASEKARAN R, WEST JK, GONZALES PC, et al.Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis[J].Am J Gastroenterol, 2010, 105 (3) :635-641. [73]WONG F.Recent advances in our understanding of hepatorenal syndrome[J].Nat Rev Gastroenterol Hepatol, 2012, 9 (7) :382-391. [74]GINES P, CARDENAS A, ARROYO V, et al.Management of cirrhosis and ascites[J].N Engl J Med, 2004, 350 (16) :1646-1654. [75]BRENSING KA, TEXTOR J, PERZ J, et al.Long term outcome after transjugular intrahepatic portosystemic stent-shunt in nontransplant cirrhotics with hepatorenal syndrome:a phase II study[J].Gut, 2000, 47 (2) :288-295. [76]WONG F, SNIDERMAN K, LIU P, et al.Transjugular intrahepatic portosystemic stent shunt:effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites[J].Ann Intern Med, 1995, 122 (11) :816-822. [77]GUEVARA M, GINES P, BANDI JC, et al.Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome:effects on renal function and vasoactive systems[J].Hepatology, 1998, 28 (2) :416-422. [78]LUDWIG J, HASHIMOTO E, Mc GILL DB, et al.Classification of hepatic venous outflow obstruction:ambiguous terminology of the Budd-Chiari syndrome[J].Mayo Clin Proc, 1990, 65 (1) :51-55. [79]VALLA D, HADENGUE A, el YOUNSI M, et al.Hepatic venous outflow block caused by short-length hepatic vein stenoses[J].Hepatology, 1997, 25 (4) :814-819. [80]QI X, WU F, REN W, et al.Thrombotic risk factors in Chinese Budd-Chiari syndrome patients.An observational study with a systematic review of the literature[J].Thromb Haemost, 2013, 109 (5) :878-884. [81]DARWISH MURAD S, PLESSIER A, HERNANDEZ-GUERRA M, et al.Etiology, management, and outcome of the Budd-Chiari syndrome[J].Ann Intern Med, 2009, 151 (3) :167-175. [82]FISHER NC, Mc CAFFERTY I, DOLAPCI M, et al.Managing Budd-Chiari syndrome:a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting[J].Gut, 1999, 44 (4) :568-574. [83]ZHANG CQ, FU LN, XU L, et al.Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome[J].World J Gastroenterol, 2003, 9 (11) :2587-2591. [84]HAN G, QI X, ZHANG W, et al.Percutaneous recanalization for Budd-Chiari syndrome:an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center[J].Radiology, 2013, 266 (2) :657-667. [85]QI X, GUO W, HE C, et al.Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome:techniques, indications and results on 51 Chinese patients from a single centre[J].Liver Int, 2014, 34 (8) :1164-1175. [86]HERNANDEZ-GUERRA M, TURNES J, RUBINSTEIN P, et al.PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome[J].Hepatology, 2004, 40 (5) :1197-1202. [87]GARCIA-PAGN JC, HEYDTMANN M, RAFFA S, et al.TIPS for Budd-Chiari syndrome:long-term results and prognostics factors in124 patients[J].Gastroenterology, 2008, 135 (3) :808-815. [88]HAYEK G, RONOT M, PLESSIER A, et al.Long-term outcome and analysis of dysfunction of transjugular intrahepatic portosystemic shunt placement in chronic primary budd-chiari syndrome[J].Radiology, 2017, 283 (1) :280-292. [89]RAUTOU PE, MOUCARI R, ESCOLANO S, et al.Prognostic indices for Budd-Chiari syndrome:valid for clinical studies but insufficient for individual management[J].Am J Gastroenterol, 2009, 104 (5) :1140-1146. [90]SALEM R, VOUCHE M, BAKER T, et al.Pretransplant portal vein recanalization-transjugular intrahepatic portosystemic shunt in patients with complete obliterative portal vein thrombosis[J].Transplantation, 2015, 99 (11) :2347-2355. [91]HAN G, QI X, HE C, et al.Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis[J].J Hepatol, 2011, 54 (1) :78-88. [92]LUCA A, MIRAGLIA R, CARUSO S, et al.Short-and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis[J].Gut, 2011, 60 (6) :846-852. [93]HABIB A, DESAI K, HICKEY R, et al.Portal vein recanalization-transjugular intrahepatic portosystemic shunt using the transsplenic approach to achieve transplant candidacy in patients with chronic portal vein thrombosis[J].J Vasc Interv Radiol, 2015, 26 (4) :499-506. [94]FANELLI F, ANGELONI S, SALVATORI FM, et al.Transjugular intrahepatic portosystemic shunt with expanded-polytetrafuoroethylene-covered stents in non-cirrhotic patients with portal cavernoma[J].Dig Liver Dis, 2011, 43 (1) :78-84. [95]QI X, HAN G, YIN Z, et al.Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients[J].Dig Dis Sci, 2012, 57 (4) :1072-1082. [96]CHEN H, TURON F, HERNANDEZ-GEA V, et al.Nontumoral portal vein thrombosis in patients awaiting liver transplantation[J].Liver Transpl, 2016, 22 (3) :352-365. [97]DARIUSHNIA SR, HASKAL ZJ, MIDIA M, et al.Quality improvement guidelines for transjugular intrahepatic portosystemic shunts[J].J Vasc Interv Radiol, 2016, 27 (1) :1-7. [98]RUIZ-DEL-ARBOL L, ACHECAR L, SERRADILLA R, et al.Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine[J].Hepatology, 2013, 58 (5) :1732-1741. [99]NAZAR A, GUEVARA M, SITGES M, et al.LEFT ventricular function assessed by echocardiography in cirrhosis:relationship to systemic hemodynamics and renal dysfunction[J].J Hepatol, 2013, 58 (1) :51-57. [100]DEBERNARDI-VENON W, BANDI JC, GARCIA-PAGAN JC, et al.CO (2) wedged hepatic venography in the evaluation of portalhypertension[J].Gut, 2000, 46 (6) :856-860. [101]SZE DY, MAGSAMEN KE, FRISOLI JK.Successful transfemoral creation of an intrahepatic portosystemic shunt with use of the Viatorr device[J].J Vasc Interv Radiol, 2006, 17 (3) :569-572. [102]BOSCH J, ABRALDES JG, BERZIGOTTI A, et al.The clinical use of HVPG measurements in chronic liver disease[J].Nat Rev Gastroenterol Hepatol, 2009, 6 (10) :573-582. [103]GAZZERA C, FONIO P, GALLESIO C, et al.Ultrasoundguided transhepatic puncture of the hepatic veins for TIPS placement[J].Radiol Med, 2013, 118 (3) :379-385. [104]PETERSEN BD, CLARK TW.Direct intrahepatic portocaval shunt[J].Tech Vasc Interv Radiol, 2008, 11 (4) :230-234. [105]PERARNAU JM, Le GOUGE A, NICOLAS C, et al.Covered vs.uncovered stents for transjugular intrahepatic portosystemic shunt:a randomized controlled trial[J].J Hepatol, 2014, 60 (5) :962-968. [106]SILVA-JUNIOR G, BAIGES A, TURON F, et al.The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique[J].Hepatology, 2015, 62 (5) :1584-1592. [107]La MURA V, ABRALDES JG, BERZIGOTTI A, et al.Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis:a clinical-hemodynamic correlation study[J].Hepatology, 2010, 51 (6) :2108-2116. [108]CASADO M, BOSCH J, GARCIA-PAGAN JC, et al.Clinical events after transjugular intrahepatic portosystemic shunt:correlation with hemodynamic findings[J].Gastroenterology, 1998, 114 (6) :1296-1303. [109]ROSSLE M, SIEGERSTETTER V, OLSCHEWSKI M, et al.How much reduction in portal pressure is necessary to prevent variceal rebleeding?A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts[J].Am J Gastroenterol, 2001, 96 (12) :3379-3383. [110]QI X, LIU L, BAI M, et al.Transjugular intrahepatic portosystemic shunt in combination with or without variceal embolization for the prevention of variceal rebleeding:a meta-analysis[J].J Gastroenterol Hepatol, 2014, 29 (4) :688-696. [111]WU W, HE C, HAN G.Embolization of spontaneous splenorenal shunt for after-TIPS hepatic encephalopathy in a patient with cirrhosis and variceal bleeding[J].Hepatology, 2015, 61 (5) :1761-1762. [112]YANG Z, HAN G, WU Q, et al.Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents:a meta-analysis[J].J Gastroenterol Hepatol, 2010, 25 (11) :1718-1725. [113]BAI M, HE CY, QI XS, et al.Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt[J].World J Gastroenterol, 2014, 20 (3) :774-785. [114]VILSTRUP H, AMODIO P, BAJAJ J, et al.Hepatic encephalopathy in chronic liver disease:2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver[J].Hepatology, 2014, 60 (2) :715-735. [115]BAI M, QI X, YANG Z, et al.Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients:a systematic review[J].J Gastroenterol Hepatol, 2011, 26 (6) :943-951. [116]RIGGIO O, NARDELLI S, PASQUALE C, et al.No effect of albumin infusion on the prevention of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J].Metab Brain Dis, 2016, 31 (6) :1275-1281. [117]RIGGIO O, NARDELLI S, MOSCUCCI F, et al.Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J].Clin Liver Dis, 2012, 16 (1) :133-146. [118]PEREIRA K, CARRION AF, MARTIN P, et al.Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy[J].Liver Int, 2015, 35 (12) :2487-2494. -
本文二维码
计量
- 文章访问数: 3125
- HTML全文浏览量: 27
- PDF下载量: 666
- 被引次数: 0
下载:
